Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Guo, Tian Zhi ^a   Wei, Tzuping ^a   Shi, Xiaoyou ^a,b   Li, Wen Wu ^a,b   Hou, Saiyun ^a   Wang, Liping ^a   Tsujikawa, Kazutake ^c   Rice, Kenner C ^d   Cheng, Kejun ^d   Clark, David J ^a,b   Kingery, Wade S ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OSAKA UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Calcitonin gene related peptide; Complex regional pain syndrome; Cytokine; Fracture; Inflammation; Nerve growth factor; Pain; Substance P

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CYTOKINE RECEPTOR ANTAGONIST; INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; SUBSTANCE P; TB 2 081; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEX REGIONAL PAIN SYNDROME; CONTROLLED STUDY; DRUG EFFECT; FEMUR; HEAT; INFLAMMATION; KERATINOCYTE; LEG EDEMA; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TIBIA FRACTURE; UPREGULATION; WILD TYPE;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; COMPLEX REGIONAL PAIN SYNDROMES; HYPERALGESIA; INFLAMMATION; MICE; MICE, MUTANT STRAINS; NERVE GROWTH FACTOR; NEUROPEPTIDES; PAIN; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; TIBIAL FRACTURES;

EID: 84870055568     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-85     Document Type: Article

References (57)

1. Subarrao J, Stillwell GK. Reflex sympathetic dystrophy syndrome of the upper extremity: analysis of total outcome of management of 125 cases. Arch Phys Med Rehab 1981, 62:549-554.
2. Backonja M, Arndt G, Gombar KA, Check B, Zimmermannm M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain 1994, 56:51-57. 10.1016/0304-3959(94)90149-X, 8159441.
3. de Mos M, Huygen FJ, van der Hoeven-Borgman M, Dieleman JP, Ch Stricker BH, Sturkenboom MC. Outcome of the complex regional pain syndrome. Clin J Pain 2009, 25:590-597. 10.1097/AJP.0b013e3181a11623, 19692800.
4. Rowbotham MC. Pharmacologic management of complex regional pain syndrome. Clin J Pain 2006, 22:425-429. 10.1097/01.ajp.0000194281.74379.01, 16772796.
5. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997, 73:123-139. 10.1016/S0304-3959(97)00049-3, 9415498.
6. Kingery WS. Complex regional pain syndrome. Physical medicine and rehabilitation; The complete approach 2000, 1101-1125. Malden, MA: Blackwell Science, Grabois M, Garrison SJ, Hart KA, Lehmkuhl LD.
7. de Mos M, de Bruijn AG, Huygen FJ, Dieleman JP, Stricker BH, Sturkenboom MC. The incidence of complex regional pain syndrome: a population-based study. Pain 2007, 129:12-20. 10.1016/j.pain.2006.09.008, 17084977.
8. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003, 103:199-207. 10.1016/S0304-3959(03)00065-4, 12749974.
9. Guo TZ, Offley SC, Boyd EA, Jacobs CR, Kingery WS. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I. Pain 2004, 108:95-107. 10.1016/j.pain.2003.12.010, 15109512.
10. Renier JC, Arlet J, Bregeon S, Basle M, Seret P. L'articulation dans l'algodystrophie. Rev Rhumat 1983, 50:255-260.
11. Tilman PBJ. Histopathologic findings in skeletal muscle tissue of patients suffering from reflex sympathetic dystrophy. Micron Microscopica Acta 1990, 21:271-272.
12. Veldman PHJM, Reynen HM, Arntz IE, Goris RJA. Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. Lancet 1993, 342:1012-1016. 10.1016/0140-6736(93)92877-V, 8105263.
13. Calder JS, Holten I, McAllister RMR. Evidence for immune system involvement in reflex sympathetic dystrophy. J Hand Surg 1998, 23B:147-150.
14. Ribbers GM, Oosterhuis WP, van Limbeek J, De metz M. Reflex sympathetic dystrophy: is the immune system involved?. Arch Phys Med Rehabil 1998, 79:1549-1552. 10.1016/S0003-9993(98)90418-X, 9862298.
15. Kozin F, McCarty D, Sims J, Genant H. The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. Am J Med 1976, 60:321-331. 10.1016/0002-9343(76)90747-6, 56891.
16. Wei T, Sabsovich I, Guo TZ, Shi X, Zhao R, Li W, Geis C, Sommer C, Kingery WS, Clark DJ. Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome. Eur J Pain 2009, 13:253-262. 10.1016/j.ejpain.2008.04.014, 2673487, 18554967.
17. Weber M, Birklein F, Neundorfer B, Schmelz M. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001, 91:251-257. 10.1016/S0304-3959(00)00445-0, 11275381.
18. Leis S, Weber M, Isselmann A, Schmelz M, Birklein F. Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome. Exp Neurol 2003, 183:197-204. 10.1016/S0014-4886(03)00163-8, 12957502.
19. Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clin J Pain 2006, 22:235-239. 10.1097/01.ajp.0000169669.70523.f0, 16514322.
20. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001, 57:2179-2184.
21. Blair SJ, Chinthagada M, Hoppenstehdt D, Kijowski R, Fareed J. Role of neuropeptides in pathogenesis of reflex sympathetic dystrophy. Acta Orthop Belg 1998, 64:448-451.
22. Wei T, Li WW, Guo TZ, Zhao R, Wang L, Clark DJ, Oaklander AL, Schmelz M, Kingery WS. Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I. Pain 2009, 144:278-286. 10.1016/j.pain.2009.04.020, 2706925, 19464118.
23. Huygen FJ, De Bruijn AG, De Bruin MT, Groeneweg JG, Klein J, Zijistra FJ. Evidence for local inflammation in complex regional pain syndrome type 1. Mediators Inflamm 2002, 11:47-51. 10.1080/09629350210307, 1781643, 11930962.
24. Huygen FJ, Ramdhani N, van Toorenenbergen A, Klein J, Zijlstra FJ. Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1. Immunol Lett 2004, 91:147-154. 10.1016/j.imlet.2003.11.013, 15019283.
25. Kramer HH, Eberle T, Uceyler N, Wagner I, Klonschinsky T, Muller LP, Sommer C, Birklein F. TNF-alpha in CRPS and 'normal' trauma-significant differences between tissue and serum. Pain 2011, 152:285-290. 10.1016/j.pain.2010.09.024, 20947251.
26. Sabsovich I, Guo TZ, Wei T, Zhao R, Li X, Clark DJ, Geis C, Sommer C, Kingery WS. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I. Pain 2008, 137:507-519. 10.1016/j.pain.2007.10.013, 2529181, 18035493.
27. Sabsovich I, Wei T, Guo TZ, Zhao R, Shi X, Li X, Yeomans DC, Klyukinov M, Kingery WS, Clark JD. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain 2008, 138:47-60. 10.1016/j.pain.2007.11.004, 2538487, 18083307.
28. Li WW, Guo TZ, Li XQ, Kingery WS, Clark JD. Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain 2010, 151:843-852. 10.1016/j.pain.2010.09.026, 2972360, 20934254.
29. Li WW, Sabsovich I, Guo TZ, Zhao R, Kingery WS, Clark JD. The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain 2009, 144:303-313. 10.1016/j.pain.2009.04.033, 2743308, 19473768.
30. Weidner C, Klede M, Rukwied R, Lischetzki G, Neisius U, Skov PS. Acute effects of substance P and calcitonin gene-related peptide in human skin-a microdialysis study. J Invest Dermatol 2000, 115:1015-1020. 10.1046/j.1523-1747.2000.00142.x, 11121135.
31. Oyen WJ, Arntz IE, Claessens RM, Van der Meer JW, Corstens FH, Goris RJ. Reflex sympathetic dystrophy of the hand: an excessive inflammatory response?. Pain 1993, 55:151-157. 10.1016/0304-3959(93)90144-E, 8309706.
32. De Jongh RF, Vissers KC, Meert TF, Booij LH, De Deyne CS, Heylen RJ. The role of interleukin-6 in nociception and pain. Anesth Analg 2003, 96:1096-1103. table of contents.
33. Jin X, Gereau RW. Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha. J Neurosci 2006, 26:246-255. 10.1523/JNEUROSCI.3858-05.2006, 16399694.
34. Pezet S, McMahon SB. Neurotrophins: mediators and modulators of pain. Annu Rev Neurosci 2006, 29:507-538. 10.1146/annurev.neuro.29.051605.112929, 16776595.
35. Massaad CA, Safieh-Garabedian B, Poole S, Atweh SF, Jabbur SJ, Saade NE. Involvement of substance P, CGRP and histamine in the hyperalgesia and cytokine upregulation induced by intraplantar injection of capsaicin in rats. J Neuroimmunol 2004, 153:171-182. 10.1016/j.jneuroim.2004.05.007, 15265675.
36. Saade NE, Massaad CA, Ochoa-Chaar CI, Jabbur SJ, Safieh-Garabedian B, Atweh SF. Upregulation of proinflammatory cytokines and nerve growth factor by intraplantar injection of capsaicin in rats. J Physiol 2002, 545:241-253. 10.1113/jphysiol.2002.028233, 2290671, 12433964.
37. Burbach GJ, Kim KH, Zivony AS, Kim A, Aranda J, Wright S, Naik SM, Caughman SW, Ansel JC, Armstrong CA. The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor. J Invest Dermatol 2001, 117:1075-1082. 10.1046/j.0022-202x.2001.01498.x, 11710915.
38. Shi X, Wang L, Li X, Sahbaie P, Kingery WS, Clark JD. Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1beta production in keratinocytes. Anesth Analg 2011, 113:175-183. 10.1213/ANE.0b013e31821a0258, 3123433, 21596883.
39. Dallos A, Kiss M, Polyanka H, Dobozy A, Kemeny L, Husz S. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 2006, 40:251-263. 10.1016/j.npep.2006.06.002, 16904178.
40. Sarangi PP, Ward AJ, Smith EJ, Staddon GE, Atkins RM. Algodystrophy and osteoporosis after tibial fractures. J Bone Joint Surg Br 1993, 75:450-452.
41. Wang L, Zhao R, Shi X, Wei T, Halloran BP, Clark DJ, Jacobs CR, Kingery WS. Substance P stimulates bone marrow stromal cell osteogenic activity, osteoclast differentiation, and resorption activity in vitro. Bone 2009, 45:309-320. 10.1016/j.bone.2009.04.203, 2706279, 19379851.
42. Davidoff G, Morey K, Amann M, Stamps J. Pain measurement in reflex sympathetic dystrophy syndrome. Pain 1988, 32:27-34. 10.1016/0304-3959(88)90020-6, 3340421.
43. Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science 1987, 235:893-895. 10.1126/science.2433770, 2433770.
44. Sakai K, Matsuno H, Tsuji H, Tohyama M. Substance P receptor (NK1) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1998, 27:135-141. 10.1080/030097498441010, 9572640.
45. Wakamatsu K, Nanki T, Miyasaka N, Umezawa K, Kubota T. Effect of a small molecule inhibitor of nuclear factor-kappaB nuclear translocation in a murine model of arthritis and cultured human synovial cells. Arthritis Res Ther 2005, 7:R1348-R1359. 10.1186/ar1834, 1297584, 16277688.
46. Gradl G, Finke B, Schattner S, Gierer P, Mittlmeier T, Vollmar B. Continuous intra-arterial application of substance P induces signs and symptoms of experimental complex regional pain syndrome (CRPS) such as edema, inflammation and mechanical pain but no thermal pain. Neuroscience 2007, 148:757-765. 10.1016/j.neuroscience.2007.06.024, 17686587.
47. Dionne RA, Max MB, Gordon SM, Parada S, Sang C, Gracely RH, Sethna NF, MacLean DB. The substance P receptor antagonist CP-99,994 reduces acute postoperative pain. Clin Pharmacol Ther 1998, 64:562-568. 10.1016/S0009-9236(98)90140-0, 9834049.
48. Sahbaie P, Shi X, Guo TZ, Qiao Y, Yeomans DC, Kingery WS, Clark JD. Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain 2009, 145:341-349. 10.1016/j.pain.2009.06.037, 2746201, 19660865.
49. Hewitt DJ, Aurora SK, Dodick DW, Goadsby PJ, Ge YJ, Bachman R, Taraborelli D, Fan X, Assaid C, Lines C, Ho TW. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia 2011, 31:712-722. 10.1177/0333102411398399, 21383045.
50. Vardanyan M, Melemedjian OK, Price TJ, Ossipov MH, Lai J, Roberts E, Boos TL, Deschamps JR, Jacobson AE, Rice KC, Porreca F. Reversal of pancreatitis-induced pain by an orally available, small molecule interleukin-6 receptor antagonist. Pain 2010, 151:257-265. 10.1016/j.pain.2010.05.022, 3313485, 20599324.
51. Tsujikawa K, Yayama K, Hayashi T, Matsushita H, Yamaguchi T, Shigeno T, Ogitani Y, Hirayama M, Kato T, Fukada S, et al. Hypertension and dysregulated proinflammatory cytokine production in receptor activity-modifying protein 1-deficient mice. Proc Natl Acad Sci USA 2007, 104:16702-16707. 10.1073/pnas.0705974104, 2034234, 17923674.
52. Cao YQ, Mantyh PW, Carlson EJ, Gillespie AM, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998, 392:390-394. 10.1038/32897, 9537322.
53. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9, 7990513.
54. Poree LR, Guo TZ, Kingery WS, Maze M. The analgesic potency of dexmedetomidine is enhanced after nerve injury: a possible role for peripheral alpha2-adrenoceptors. Anesth Analg 1998, 87:941-948.
55. Clark JD, Qiao Y, Li X, Shi X, Angst MS, Yeomans DC. Blockade of the complement C5a receptor reduces incisional allodynia, edema, and cytokine expression. Anesthesiology 2006, 104:1274-1282. 10.1097/00000542-200606000-00024, 16732100.
56. Hildebrand T, Ruegsegger P. Quantification of bone microarchitecture with the structure model index. Comput Methods Biomech Biomed Engin 1997, 1:15-23. 10.1080/01495739708936692, 11264794.
57. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P. Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res 1999, 14:1167-1174. 10.1359/jbmr.1999.14.7.1167, 10404017.